AzTrials
AzTrials

Panic DisorderNCT07247955

Guided and Traditional Cognitive Behavioral Therapy Protocol for Resistant Panic

A study testing The group intervention used the sessions described in traditional form and The group intervention used the sessions described in a self-guided format using an application in people with Panic Disorder, run by Universidade Federal do Rio de Janeiro at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Self-guided therapy for anxiety disorders has focused on various cognitive-behavioral treatments mediated by technologies such as web applications. This study aims to compare two groups of patients with panic disorder undergoing two clinical psychological treatment models: one traditional cognitive behavioral therapy… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Panic Disorder
What is being tested?
The group intervention used the sessions described in traditional form and The group intervention used the sessions described in a self-guided format using an application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteBrazil
Study dates
5 Apr 2023to 2 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients undergoing IPUB screening through the panic and respiratory laboratory outpatient clinic.
  • Diagnosis of panic disorder confirmed.
  • Age between 18 and 60 years.
  • Under psychiatric follow-up by a university psychiatrist and taking medication.
  • Provide written informed consent to participate and have data stored.

Who cannot join

  • Patients without a diagnosis of panic disorder.
  • Age under 18 or over 60 years.
  • Not undergoing psychiatric follow-up.
  • Presence of other psychiatric or medical diagnoses.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Universidade Federal do Rio de JAneiro

    Rio de Janeiro, Rio de Janeiro, Tel. (+55 21) 25216147

Other trials in Brazil

About this study

Official title: Effectiveness of the Guided and Traditional Cognitive Behavioral Therapy Protocol in a Patient With Treatment-resistant Panic Disorder

Self-guided therapy for anxiety disorders has focused on various cognitive-behavioral treatments mediated by technologies such as web applications. This study aims to compare two groups of patients with panic disorder undergoing two clinical psychological treatment models: one traditional cognitive behavioral therapy (CBT), and the other self-guided CBT using a digital application.

An application was developed in which both treatment models follow the same eight-session CBT manual. Patients are evaluated using psychological assessments at the first and eighth sessions.

The study includes 46 patients divided into two groups of 23 participants each. Both groups undergo individual assessments at the beginning and end of the treatment protocol.

Read the detailed description

As such, an application was developed whereby the two models follow the same treatment manual of eight sessions, with the patients being evaluated using psychological tests at the first and eighth sessions.

Methods: A total of 46 patients were separated into two groups of 23 patients, one in each format, with the patients in both groups being individually evaluated at their first and eighth sessions.

Conditions
Panic Disorder
Being tested
The group intervention used the sessions described in traditional form, The group intervention used the sessions described in a self-guided format using an application
Keywords
Panic disorder, Cognitive behavioral therapy, Application
Medical subject headings
Panic Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The group intervention used the sessions described in traditional formBehavioural

    Model of the sessions:

    • Session 1 - General information for the Client
    • Session 2 - Breaking the panic cycle
    • Session 3 - Increasing the range of cognitive management skills
    • Session 4 - Improving corporal management skills
    • Session 5 - Strengthening self-efficacy
    • Session 6 - Stimulating life reorientation
    • Session 7 - Promoting existential management
    • Session 8 - Revising and evaluating the treatment
  • The group intervention used the sessions described in a self-guided format using an applicationBehavioural

    Model of the sessions:

    • Session 1 - General information for the Client
    • Session 2 - Breaking the panic cycle
    • Session 3 - Increasing the range of cognitive management skills
    • Session 4 - Improving corporal management skills
    • Session 5 - Strengthening self-efficacy
    • Session 6 - Stimulating life reorientation
    • Session 7 - Promoting existential management
    • Session 8 - Revising and evaluating the treatment
Study groups in NCT07247955
Study groupRoleWhat they receive
Group of 23 patients undergoing traditional cognitive behavioral therapyExperimentalTwenty-three patients were selected for group. The group consisted of patients with panic disorder and breathing difficulties in a traditional cognitive behavioral therapy format, 8-session treatment protocol.
Receives: Behavioral: The group intervention used the sessions described in traditional form
Group of 23 patients undergoing self-guided cognitive behavioral therapy using an appExperimentalTwenty-three patients were selected for group. The group consisted of patients with panic disorder and breathing difficulties in a self-guided cognitive behavioral therapy format, using the 8-session treatment protocol.
Receives: Behavioral: The group intervention used the sessions described in a self-guided format using an application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy criteria

    Primary Outcome Measure 1 Title: Beck Anxiety Inventory (BAI) total score Time Frame: Baseline (Week 1) and Post-intervention (Week 8) Description: The BAI is a 21-item self-report questionnaire that measures the severity of anxiety symptoms. Total scores range from 0 to 63; higher scores indicate greater anxiety. Administered to all participants in both groups. Results will be reported separately for each time point.

    Unit of Measure: Points on a scale (0-63) Primary Outcome Measure 2 Title: Beck Depression Inventory (BDI) total score Time Frame: Baseline (Week 1) and Post-intervention (Week 8) Description: The BDI is a 21-item self-report inventory assessing depressive symptoms. Scores range from 0 to 63, with higher scores indicating greater severity of depression. Applied to all participants in both groups, with separate reporting for each assessment.

    Unit of Measure: Points on a scale (0-63)

    Measured: Baseline (Week 1) and Post-intervention (Week 8)

Secondary outcomes (1)
  1. Efficacy criteria

    Outcome Measure 3 Title: Mindful Attention Awareness Scale (MAAS) total score Time Frame: Baseline (Week 1) and Post-intervention (Week 8) Description: The MAAS is a 15-item scale measuring mindfulness in daily life. Scores range from 15 to 90; higher scores reflect greater mindfulness. Administered to all participants. Scores will be reported separately at each time point.

    Unit of Measure: Points on a scale (15-90) Outcome Measure 4 Title: Brief Resilient Coping Scale (BRCS) total score Time Frame: Baseline (Week 1) and Post-intervention (Week 8) Description: The BRCS is a 4-item scale assessing the tendency to cope with stress in a resilient manner. Scores range from 4 to 20; higher scores indicate more adaptive coping. Administered to both groups. Each time point reported separately.

    Unit of Measure: Points on a scale (4-20)

    Measured: Baseline (Week 1) and Post-intervention (Week 8)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start5 Apr 2023
  3. Primary completion15 Oct 2024
  4. Study completion2 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Model description
As a pilot study comparing two groups of patients with PD in different forms of care, the data from 23 patients with panic disorder undergoing traditional CBT and 23 patients with panic disorder doing self-guided therapy through an application were collected. The groups were randomized, they had no comorbidities, all patients were undergoing psychiatric follow-up.
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07247955
Sponsor's protocol ID
UFRJ-2025-001
Status last verified
May 2025
First submitted
22 May 2025
Last updated
25 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gal E, Stefan S, Cristea IA. The efficacy of mindfulness meditation apps in enhancing users' well-being and mental health related outcomes: a meta-analysis of randomized controlled trials. J Affect Disord. 2021 Jan 15;279:131-142. doi: 10.1016/j.jad.2020.09.134. Epub 2020 Oct 7.

    PubMed 33049431
  • Yogeswaran V, El Morr C. Effectiveness of online mindfulness interventions on medical students' mental health: a systematic review. BMC Public Health. 2021 Dec 18;21(1):2293. doi: 10.1186/s12889-021-12341-z.

    PubMed 34920715
  • Linardon J. Can Acceptance, Mindfulness, and Self-Compassion Be Learned by Smartphone Apps? A Systematic and Meta-Analytic Review of Randomized Controlled Trials. Behav Ther. 2020 Jul;51(4):646-658. doi: 10.1016/j.beth.2019.10.002. Epub 2019 Nov 26.

    PubMed 32586436
  • Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2012 Nov 14;11:CD006611. doi: 10.1002/14651858.CD006611.pub3.

    PubMed 23152238
  • Bakker D, Kazantzis N, Rickwood D, Rickard N. Mental Health Smartphone Apps: Review and Evidence-Based Recommendations for Future Developments. JMIR Ment Health. 2016 Mar 1;3(1):e7. doi: 10.2196/mental.4984.

    PubMed 26932350
  • Loucas CE, Fairburn CG, Whittington C, Pennant ME, Stockton S, Kendall T. E-therapy in the treatment and prevention of eating disorders: A systematic review and meta-analysis. Behav Res Ther. 2014 Dec;63:122-31. doi: 10.1016/j.brat.2014.09.011. Epub 2014 Oct 5.

    PubMed 25461787
  • Schueller SM, Torous J. Scaling evidence-based treatments through digital mental health. Am Psychol. 2020 Nov;75(8):1093-1104. doi: 10.1037/amp0000654.

    PubMed 33252947
  • Wu J, Ma Y, Zuo Y, Zheng K, Zhou Z, Qin Y, Ren Z. Effects of Mindfulness Exercise Guided by a Smartphone App on Negative Emotions and Stress in Non-Clinical Populations: A Systematic Review and Meta-Analysis. Front Public Health. 2022 Jan 25;9:773296. doi: 10.3389/fpubh.2021.773296. eCollection 2021.

    PubMed 35155341
  • Rathbone AL, Clarry L, Prescott J. Assessing the Efficacy of Mobile Health Apps Using the Basic Principles of Cognitive Behavioral Therapy: Systematic Review. J Med Internet Res. 2017 Nov 28;19(11):e399. doi: 10.2196/jmir.8598.

    PubMed 29187342
  • Hansen WB, Scheier LM. Specialized Smartphone Intervention Apps: Review of 2014 to 2018 NIH Funded Grants. JMIR Mhealth Uhealth. 2019 Jul 29;7(7):e14655. doi: 10.2196/14655.

    PubMed 31359866
  • Hwang WJ, Ha JS, Kim MJ. Research Trends on Mobile Mental Health Application for General Population: A Scoping Review. Int J Environ Res Public Health. 2021 Mar 2;18(5):2459. doi: 10.3390/ijerph18052459.

    PubMed 33801537
  • Firth J, Torous J, Carney R, Newby J, Cosco TD, Christensen H, Sarris J. Digital Technologies in the Treatment of Anxiety: Recent Innovations and Future Directions. Curr Psychiatry Rep. 2018 May 19;20(6):44. doi: 10.1007/s11920-018-0910-2.

    PubMed 29779065
  • Wright JH, Mishkind M, Eells TD, Chan SR. Computer-Assisted Cognitive-Behavior Therapy and Mobile Apps for Depression and Anxiety. Curr Psychiatry Rep. 2019 Jun 27;21(7):62. doi: 10.1007/s11920-019-1031-2.

    PubMed 31250242
  • Khademian F, Aslani A, Bastani P. The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews. Int J Technol Assess Health Care. 2020 Dec 14;37:e4. doi: 10.1017/S0266462320002093.

    PubMed 33314997
  • Ito LM, Noshirvani H, Basoglu M, Marks IM. Does exposure to internal cues enhance exposure to external cues in agoraphobia with panic? A pilot controlled study of self-exposure. Psychother Psychosom. 1996;65(1):24-28. doi: 10.1159/000289027.

    PubMed 8838693

Questions about this trial

What is this clinical trial studying?

A study testing The group intervention used the sessions described in traditional form and The group intervention used the sessions described in a self-guided format using an application in people with Panic Disorder, run by Universidade Federal do Rio de Janeiro at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy criteria (time frame: Baseline (Week 1) and Post-intervention (Week 8)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07247955, which also lists 17 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07247955 | AzTrials